DEERFIELD MANAGEMENT COMPANY, L.P. Q3 2022 Filing
Filed November 14, 2022
Portfolio Value
$5.0B
Holdings
130
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (130 positions)
| Stock | Value |
|---|---|
NUVLNUVALENT INC | $376.0M |
GKOS 2.75 06/15/27GLAUKOS CORP | $355.8M |
—AERIE PHARMACEUTICALS INC | $170.8M |
—INVITAE CORP | $162.2M |
NBIXNEUROCRINE BIOSCIENCES INC | $160.7M |
AHCOADAPTHEALTH CORP | $154.4M |
SRPT 1.5 11/15/24SAREPTA THERAPEUTICS INC | $148.3M |
IONS 0 04/01/26IONIS PHARMACEUTICALS INC | $128.5M |
—TABULA RASA HEALTHCARE INC | $115.5M |
SILKSILK RD MED INC | $114.1M |
—CAREMAX INC | $112.5M |
APLS 3.5 09/15/26APELLIS PHARMACEUTICALS INC | $99.1M |
GILDGILEAD SCIENCES INC | $94.9M |
OPHTEURIVERIC BIO INC | $94.1M |
GMED 1 06/01/23NUVASIVE INC | $93.7M |
VTRSVIATRIS INC | $90.9M |
BIIBBIOGEN INC | $88.1M |
ATEC 0.75 08/01/26ALPHATEC HLDGS INC | $81.4M |
—INTERCEPT PHARMACEUTICALS IN | $81.1M |
PCRX 0.75 08/01/25PACIRA BIOSCIENCES INC | $80.8M |
ACCD 0.5 04/01/26ACCOLADE INC | $79.1M |
AERIEURAERIE PHARMACEUTICALS INC | $73.5M |
INSM 1.75 01/15/25INSMED INC | $73.2M |
IMGNEURIMMUNOGEN INC | $65.7M |
GH 0 11/15/27GUARDANT HEALTH INC | $65.0M |
CPRXCATALYST PHARMACEUTICALS INC | $62.8M |
LUNGPULMONX CORP | $62.0M |
RVMDREVOLUTION MEDICINES INC | $57.0M |
—INTERCEPT PHARMACEUTICALS IN | $56.1M |
LRMRLARIMAR THERAPEUTICS INC | $54.2M |
OSH 0 03/15/26OAK STR HEALTH INC | $52.5M |
NTRA 2.25 05/01/27NATERA INC | $51.4M |
MRUSMERUS N V | $50.5M |
NSTG 2.625 03/01/25NANOSTRING TECHNOLOGIES INC | $48.7M |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $46.1M |
HLVXHILLEVAX INC | $45.3M |
COGTCOGENT BIOSCIENCES INC | $44.3M |
EOLSEVOLUS INC | $43.4M |
MIRMMIRUM PHARMACEUTICALS INC | $42.7M |
TDOC 0.875 06/01/25LIVONGO HEALTH INC | $42.0M |
NVRO 2.75 04/01/25NEVRO CORP | $39.6M |
CYTKCYTOKINETICS INC | $39.4M |
ONEM 3 06/15/251LIFE HEALTHCARE INC | $39.4M |
EWTXEDGEWISE THERAPEUTICS INC | $38.7M |
PTCT 1.5 09/15/26PTC THERAPEUTICS INC | $37.6M |
ANABANAPTYSBIO INC | $37.4M |
B7SBROOKDALE SR LIVING INC | $37.1M |
CNCCENTENE CORP DEL | $36.1M |
AMEDAMEDISYS INC | $34.8M |
PHRPHREESIA INC | $34.6M |
BLUBELLUS HEALTH INC NEW | $32.5M |
KURAKURA ONCOLOGY INC | $30.3M |
PHATPHATHOM PHARMACEUTICALS INC | $26.8M |
IDYAIDEAYA BIOSCIENCES INC | $26.0M |
VERVVERVE THERAPEUTICS INC | $25.8M |
HCAT 2.5 04/15/25HEALTH CATALYST INC | $25.5M |
MOHMOLINA HEALTHCARE INC | $24.7M |
NVAX 3.75 02/01/23NOVAVAX INC | $24.4M |
SWTXSPRINGWORKS THERAPEUTICS INC | $23.3M |
TARSTARSUS PHARMACEUTICALS INC | $22.7M |
ATECALPHATEC HLDGS INC | $22.1M |
IM8NINSMED INC | $20.7M |
DAWNDAY ONE BIOPHARMACEUTICALS I | $20.7M |
EHABENHABIT INC | $20.4M |
VIGLVIGIL NEUROSCIENCE INC | $18.0M |
—SINGULAR GENOMICS SYSTEMS IN | $17.7M |
XERS 5 07/15/25XERIS BIOPHARMA HOLDINGS INC | $17.4M |
TGTXTG THERAPEUTICS INC | $15.9M |
—DA32 LIFE SCNCE TEC ACQSTN C | $15.6M |
TOITHE ONCOLOGY INSTITUTE INC | $15.6M |
PCRXPACIRA BIOSCIENCES INC | $15.5M |
SMFRUSDSEMA4 HOLDINGS CORP | $14.9M |
RCKTROCKET PHARMACEUTICALS INC | $13.9M |
ANTXAN2 THERAPEUTICS INC | $12.5M |
KRYSKRYSTAL BIOTECH INC | $12.2M |
PACBPACIFIC BIOSCIENCES CALIF IN | $11.7M |
ADCTADC THERAPEUTICS SA | $11.5M |
VCELVERICEL CORP | $11.3M |
TERNTERNS PHARMACEUTICALS INC | $11.0M |
—EUCRATES BIOMEDICAL ACQUISIT | $10.0M |
—SARISSA CAPITAL ACQUISITN CO | $10.0M |
ALECALECTOR INC | $10.0M |
—SENIOR CONNECT ACQUISITN COR | $9.9M |
TLSIMEDTECH ACQUISITION CORP | $9.9M |
—REVOLUTION HEALTHCAR AQ CORP | $9.8M |
—APOLLO ENDOSURGERY INC | $9.6M |
PHVSPHARVARIS N V | $8.5M |
—POINT BIOPHARMA GLOBAL INC | $7.7M |
—TURMERIC ACQUISITION CORP | $7.5M |
—IGNYTE ACQUISITION CORP | $7.2M |
PEPGPEPGEN INC | $6.8M |
FHTXFOGHORN THERAPEUTICS INC | $6.7M |
INZYINOZYME PHARMA INC | $5.6M |
NEO 1.25 05/01/25NEOGENOMICS INC | $5.6M |
—GRAYBUG VISION INC | $5.0M |
—ORION ACQUISITION CORP | $4.9M |
HOWLWEREWOLF THERAPEUTICS INC | $4.3M |
QSIQUANTUM SI INC | $3.9M |
ANNXANNEXON INC | $3.6M |
ORTXUSDORCHARD THERAPEUTICS PLC | $3.5M |
Page 1 of 2Next